Barry E. Greene, Director at ACORDA THERAPEUTICS INC (ACOR), sold 723 shares at $22.65 ($16K) on 2017-02-09, disclosed to the SEC on 2017-02-13.
Scheduled sale ($16k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |